Interaction between gemcitabine and warfarin causing gastrointestinal bleeding in a patient with pancreatic cancer.
Gemcitabine (Gemzar) is the only chemotherapeutic agent approved by the U.S. Food and DrugAdministration (FDA) for the treatment of advanced pancreatic cancer. Thromboembolism requiring anticoagulation is a common paraneoplastic complication in these patients. We report a case of patient with pancre...
| Published in: | Journal of Applied Research Vol. 5; no. 3; pp. 434 - 438 |
|---|---|
| Main Author: | |
| Format: | case study Journal Article |
| Published: |
Therapeutic Solutions LLC
2005
|
| Online Access: | View this record in EBSCOhost |